New devices along with tailored medical management could extend and save patient lives while improving their quality of life. Technologies include implantable heart device therapies and left ventricular assist devices. But historically, specifically before the 1980s, explaining the changes that occurred in the heart during heart failure included only how heart disease was treated: bed rest, a restriction on physical activity, restricting fluids. As for modern treatment of ventricular dyssynchrony, it is treated with cardia resynchronization therarpy, and hemodynamically compromised patients are treated with MCS (when indicated).

Promising therapeutic strategies have been focused on managing and treating comorbidities in heart failure, and clinicians now have an arsenal of choices.